FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347,950 | -12.9% | 46,332 | +2.4% | 0.00% | – |
| Q2 2023 | $399,483 | +43.2% | 45,242 | +0.7% | 0.00% | – |
| Q1 2021 | $279,000 | -18.4% | 44,912 | -2.1% | 0.00% | – |
| Q4 2020 | $342,000 | +16.3% | 45,866 | -5.7% | 0.00% | – |
| Q3 2020 | $294,000 | -27.2% | 48,625 | +0.4% | 0.00% | – |
| Q2 2020 | $404,000 | +264.0% | 48,439 | +112.4% | 0.00% | – |
| Q1 2019 | $111,000 | -23.4% | 22,804 | 0.0% | 0.00% | – |
| Q4 2018 | $145,000 | -22.5% | 22,804 | +0.1% | 0.00% | – |
| Q3 2018 | $187,000 | -21.1% | 22,789 | 0.0% | 0.00% | – |
| Q2 2018 | $237,000 | – | 22,789 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 2,433,230 | $18,128,000 | 8.76% |
| Solas Capital Management, LLC | 800,000 | $5,960,000 | 4.55% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,375,000 | 0.53% |
| 683 Capital Management, LLC | 1,110,000 | $8,269,000 | 0.39% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $298,000 | 0.26% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,442,000 | 0.21% |
| Eventide Asset Management | 1,120,000 | $8,344,000 | 0.13% |
| Hartford Financial Management Inc. | 38,848 | $289,000 | 0.08% |
| Granahan Investment Management | 394,810 | $2,941,000 | 0.07% |
| Planned Solutions, Inc. | 800 | $6,000 | 0.01% |